Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS

NCT03534323 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

55

Enrollment

OTHER

Sponsor class

Conditions

Chronic Lymphocytic Leukemia
Richter Syndrome

Interventions

DRUG: Duvelisib
DRUG: Venetoclax

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]